Abstract:The element boron forms a wide range of borate minerals with different properties. Borate minerals make it possible to design boron-containing molecules with new biological properties in terms of their chemical structure and properties. It is known that boron compounds have antioxidant, anti-inflammatory, anti-tumor and anti-cancer properties. This makes boron compounds important for the future development of boron chemotherapeutics, boron supplements and new drugs. Reliable scientific studies on boron compounds will facilitate the clear presentation of their functions in its biological applications and metabolism. In this study, boron monoester and boron diester structures were synthesized with salicylic acid ligand. To stabilize boron ester structures, Na+, K+, Mg2+, Ca2+ cations were used as counter-ions. Structural properties of the synthesized substances, molecules obtained by crystallization/precipitation from aqueous solutions in solid state, elemental analysis, melting point determination, infrared spectroscopy analysis (FT-IR), thermal analysis (TGA/DTA), mass analysis (GC-MS) and single crystal analysis. Structural properties were tried to be explained by structure analysis (SC-XRD) methods. Additionally, the anticancer potential of boron salicylate esters against the MDA-MB-231 human breast adenocarcinoma cell line was examined. The K-B salicylate diester molecule was found to have the most potential potency with the lowest IC50 value against the MDA-MB-231 cell line. The anticancer potential of boron salicylate esters can be further investigated with other cancer models with the combination of anticancer drugs. It is also thought that the mechanism of action of these molecules may help reveal their further applications.

The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology

Boron Chemistry for Medical Applications

Recent developments in the medicinal chemistry of single boron atom-containing compounds

The Boron Advantage: The Evolution and Diversification of Boron’s Applications in Medicinal Chemistry

Correction to "The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology"

Boron in cancer therapeutics: An overview

[Basic Organic and Inorganic Chemistry of Boron Clusters and Its Application to Drug Discovery].

Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy

Synthesis of Boron-Containing Nucleoside Analogs

Sweet Boron: Boron-Containing Sugar Derivatives as Potential Agents for Boron Neutron Capture Therapy

Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers

Responsive Boron Biomaterials and Their Biomedical Applications

Boron-containing compounds as labels, drugs, and theranostic agents for diabetes and its complications

Boron nanoparticles in chemotherapy and radiotherapy: the synthesis, state-of-the-art, and prospects

A periodic development of BPA and BSH based derivatives in boron neutron capture therapy (BNCT)

New Boron Delivery Agents

Boron Salicylate Ester Compounds as Boron Therapeutics. Their Synthesis, Structural Characterizations and Anticancer Effects against MDA-MB-231

Boron enabled bioconjugation chemistries

Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy

Next-Generation Boron Drugs and Rational Translational Studies Driving the Revival of BNCT

Optimizing Boron Neutron Capture Therapy (BNCT) to Treat Cancer: An Updated Review on the Latest Developments on Boron Compounds and Strategies